PetVivo HoldingsPETV -0.12%31 Days Payable is 818.62 as of Mar. 2026, which is 65% below its 10-year median of 2,347.14. GuruFocus rates PETV with a GF Score™ of 31/100 and a GF Value™ of $0.51 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 795 Medical Devices & Instruments companies, PetVivo Holdings ranks better than 92.96% on this metric.
The historical rank and industry rank for PetVivo Holdings's Days Payable or its related term are showing as below:
PETV'
s Days Payable Range Over the Past 10 Years
Min: 540.99 Med: 2347.14 Max: 16673.86
Current: 540.99
During the past 13 years, PetVivo Holdings's highest Days Payable was 16673.86. The lowest was 540.99. And the median was 2347.14.
PETV's Days Payable is ranked better than 92.96% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs PETV: 540.99
PetVivo Holdings's Days Payable
declined
from Mar. 2025 (2,009.67) to Mar. 2026 (818.62).
It may suggest that PetVivo Holdingsaccelerated paying its suppliers.
PetVivo Holdings Days Payable Related Terms
PetVivo Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for PetVivo Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, PetVivo Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PetVivo Holdings's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetVivo Holdings (PETV) has a Days Payable of 818.62 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PetVivo Holdings and its competitors. This is 65% below median its historical median of 2,347.14. Over the past decade, PetVivo Holdings' Days Payable has ranged from 540.99 to 16,673.86. According to the industry distribution chart, PetVivo Holdings ranks #56 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 7%.
Is PetVivo Holdings' Days Payable too high?
PetVivo Holdings' current Days Payable of 818.62 is 65% below median its 10-year median of 2,347.14. Over the past 10 years, this metric has ranged from a low of 540.99 to a high of 16,673.86. The Medical Devices & Instruments industry median Days Payable is 68.07. PetVivo Holdings' value of 818.62 is 1102.6% above this industry median. Based on the distribution chart, PetVivo Holdings ranks #56 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PetVivo Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' Days Payable compare to ARAY and RDGL?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #56 out of 795 companies for Days Payable. This places PetVivo Holdings in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. PetVivo Holdings' value of 818.62 is 1102.6% above this benchmark. Historically, PetVivo Holdings' own Days Payable has ranged from 540.99 to 16,673.86 over the past decade. While the company's 10-year median is 2,347.14 vs. the industry median of 68.07, PetVivo Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetVivo Holdings's current Days Payable of 818.62 is 1102.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PetVivo Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetVivo Holdings's current Days Payable is 818.62, which is 65% below median its own 10-year median of 2,347.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.51, compared to a current price of $0.84 — trading 64.5% above its estimated fair value. The current Days Payable is 818.62, which is 65% below median its 10-year median of 2,347.14 and 1102.6% above the Medical Devices & Instruments industry median of 68.07. PetVivo Holdings' overall GF Score™ is 31/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current Days Payable is 818.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetVivo Holdings (PETV) Overvalued in 2026?
Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued.
The current stock price of $0.84 is trading 64.5% above its estimated GF Value™ of $0.51.
GuruFocus considers PetVivo Holdings to be Significantly Overvalued.
Key valuation signals for PETV:
Days Payable: 818.62 (65% below median its 10-year median of 2,347.14)
GF Value™: $0.51 vs. price of $0.84 (64.5% above fair value)
Industry Position: 1102.6% above the Medical Devices & Instruments median (#56 of 795)
No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
31GF Score
Get the complete analysis for PETV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETV has been successfully added to your 
